Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Kidney Int ; 85(6): 1318-29, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24284510

ABSTRACT

Hydrogen sulfide has recently been found decreased in chronic kidney disease. Here we determined the effect and underlying mechanisms of hydrogen sulfide on a rat model of unilateral ureteral obstruction. Compared with normal rats, obstructive injury decreased the plasma hydrogen sulfide level. Cystathionine-ß-synthase, a hydrogen sulfide-producing enzyme, was dramatically reduced in the ureteral obstructed kidney, but another enzyme cystathionine-γ-lyase was increased. A hydrogen sulfide donor (sodium hydrogen sulfide) inhibited renal fibrosis by attenuating the production of collagen, extracellular matrix, and the expression of α-smooth muscle actin. Meanwhile, the infiltration of macrophages and the expression of inflammatory cytokines including interleukin-1ß, tumor necrosis factor-α, and monocyte chemoattractant protein-1 in the kidney were also decreased. In cultured kidney fibroblasts, a hydrogen sulfide donor inhibited the cell proliferation by reducing DNA synthesis and downregulating the expressions of proliferation-related proteins including proliferating cell nuclear antigen and c-Myc. Further, the hydrogen sulfide donor blocked the differentiation of quiescent renal fibroblasts to myofibroblasts by inhibiting the transforming growth factor-ß1-Smad and mitogen-activated protein kinase signaling pathways. Thus, low doses of hydrogen sulfide or its releasing compounds may have therapeutic potentials in treating chronic kidney disease.


Subject(s)
Hydrogen Sulfide/pharmacology , Kidney Diseases/prevention & control , Kidney/drug effects , Sulfides/pharmacology , Ureteral Obstruction/drug therapy , Actins/metabolism , Animals , Cell Line , Cell Proliferation/drug effects , Collagen/metabolism , Cystathionine beta-Synthase/metabolism , Cystathionine gamma-Lyase/metabolism , Cytokines/metabolism , Cytoprotection , DNA Replication/drug effects , Disease Models, Animal , Dose-Response Relationship, Drug , Extracellular Matrix/drug effects , Extracellular Matrix/metabolism , Fibrosis , Hydrogen Sulfide/metabolism , Inflammation Mediators/metabolism , Kidney/metabolism , Kidney/pathology , Kidney Diseases/etiology , Kidney Diseases/metabolism , Kidney Diseases/pathology , Macrophages/drug effects , Macrophages/metabolism , Male , Mitogen-Activated Protein Kinases/metabolism , Nephritis, Interstitial/metabolism , Nephritis, Interstitial/pathology , Nephritis, Interstitial/prevention & control , Phosphorylation , Rats, Sprague-Dawley , Signal Transduction/drug effects , Sulfides/metabolism , Time Factors , Ureteral Obstruction/complications , Ureteral Obstruction/metabolism , Ureteral Obstruction/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...